» Articles » PMID: 9274471

Prevention of Helicobacter Pylori Infection by Lactobacilli in a Gnotobiotic Murine Model

Overview
Journal Gut
Specialty Gastroenterology
Date 1997 Jul 1
PMID 9274471
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Helicobacter pylori is a bacterium which causes gastric inflammatory diseases. Oral inoculation of H pylori usually results in only a temporary colonisation without a successful infection in the stomach of conventional mice in which lactobacilli are the predominant indigenous bacteria.

Aim: To determine whether lactobacilli exert an inhibitory effect on colonisation by H pylori in the stomach.

Methods: The effects of H pylori on attachment to murine and human gastric epithelial cells and the H pylori mediated release of interleukin-8 (IL-8) by these cells were examined in vitro. Lactobacillus salivarius infected gnotobiotic BALB/c mice and control germ free mice were inoculated orally with H pylori to examine whether L salivarius can inhibit colonisation by H pylori.

Results: L salivarius inhibited both the attachment and IL-8 release in vitro. H pylori could not colonise the stomach of L salivarius infected gnotobiotic BALB/c mice, but colonised in large numbers and subsequently caused active gastritis in germ free mice. In addition, L salivarius given after H pylori implantation could eliminate colonisation by H pylori.

Conclusion: These findings suggest the possibility of lactobacilli being used as probiotic agents against H pylori.

Citing Articles

Helicobacter pylori, microbiota and gastric cancer - principles of microorganism-driven carcinogenesis.

Wizenty J, Sigal M Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 40011753 DOI: 10.1038/s41575-025-01042-2.


Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance.

Dash D, Mishra V, Panda M, Pathak S Probiotics Antimicrob Proteins. 2024; .

PMID: 39499454 DOI: 10.1007/s12602-024-10396-z.


Delivery of Probiotic-Loaded Microcapsules in the Gastrointestinal Tract: A Review.

Heidarrezaei M, Mauriello G, Shokravi H, Lau W, Ismail A Probiotics Antimicrob Proteins. 2024; 17(1):193-211.

PMID: 38907825 DOI: 10.1007/s12602-024-10311-6.


Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following challenge.

Wan S, You P, Shi Q, Hu H, Zhang L, Chen L Front Microbiol. 2024; 15:1368194.

PMID: 38638911 PMC: 11024471. DOI: 10.3389/fmicb.2024.1368194.


Harnessing Vaginal Probiotics for Enhanced Management of Uterine Disease and Reproductive Performance in Dairy Cows: A Conceptual Review.

Adnane M, Whiston R, Tasara T, Bleul U, Chapwanya A Animals (Basel). 2024; 14(7).

PMID: 38612312 PMC: 11011061. DOI: 10.3390/ani14071073.


References
1.
Slomiany B, Piotrowski J, Samanta A, VanHorn K, MURTY V, Slomiany A . Campylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3 ganglioside. Biochem Int. 1989; 19(4):929-36. View

2.
Bhatia S, Kochar N, Abraham P, Nair N, Mehta A . Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol. 1989; 27(10):2328-30. PMC: 267018. DOI: 10.1128/jcm.27.10.2328-2330.1989. View

3.
Reid G, Bruce A, McGroarty J, Cheng K, Costerton J . Is there a role for lactobacilli in prevention of urogenital and intestinal infections?. Clin Microbiol Rev. 1990; 3(4):335-44. PMC: 358167. DOI: 10.1128/CMR.3.4.335. View

4.
Negrini R, Lisato L, Zanella I, Cavazzini L, Gullini S, Villanacci V . Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology. 1991; 101(2):437-45. DOI: 10.1016/0016-5085(91)90023-e. View

5.
Graham D, Adam E, Reddy G, Agarwal J, Agarwal R, Evans Jr D . Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991; 36(8):1084-8. DOI: 10.1007/BF01297451. View